Oleanolic Acid Slows Down Aging Through IGF-1 Affecting the PI3K/AKT/mTOR Signaling Pathway DOI Creative Commons
Yan Xu, Jun Wei, Wang Wang

et al.

Molecules, Journal Year: 2025, Volume and Issue: 30(3), P. 740 - 740

Published: Feb. 6, 2025

A pentacyclic triterpene, oleanolic acid (OA), has anti-inflammatory activity. The role of in aging is poorly understood, and the regulatory mechanism IGF-1 signaling still not fully understood. Thus, we hypothesized that OA could delay by regulating PI3K/AKT/mTOR pathway via insulin-like growth factor-1 (IGF-1). This study initially established a replicative model bleomycin-induced human dermal fibroblast (HDF) mouse embryonic (MEF) cell lines. On this basis, inhibitors or recombinant proteins were then combined with (at concentration 20 μM) treated for 72 h. project plans to detect expression aging-related such as CDKN2A (p16) using Western blot technology, factors Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8) Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR), Enzyme-Linked Immunosorbent Assay (ELISA), other technologies, combine Senescence-Associated β-Galactosidase (SA-β-gal) staining changes aging. IGF-1, PI3K/AKT/mTOR, P16, secretory (SASP) IL-1β, IL-6, IL-8 was increased senescent cells. After treatment jujuboside, protein decreased. findings suggested slowed down inhibiting through IGF-1. These suggest potential new drug its mechanisms anti-aging.

Language: Английский

Oleanolic Acid Slows Down Aging Through IGF-1 Affecting the PI3K/AKT/mTOR Signaling Pathway DOI Creative Commons
Yan Xu, Jun Wei, Wang Wang

et al.

Molecules, Journal Year: 2025, Volume and Issue: 30(3), P. 740 - 740

Published: Feb. 6, 2025

A pentacyclic triterpene, oleanolic acid (OA), has anti-inflammatory activity. The role of in aging is poorly understood, and the regulatory mechanism IGF-1 signaling still not fully understood. Thus, we hypothesized that OA could delay by regulating PI3K/AKT/mTOR pathway via insulin-like growth factor-1 (IGF-1). This study initially established a replicative model bleomycin-induced human dermal fibroblast (HDF) mouse embryonic (MEF) cell lines. On this basis, inhibitors or recombinant proteins were then combined with (at concentration 20 μM) treated for 72 h. project plans to detect expression aging-related such as CDKN2A (p16) using Western blot technology, factors Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Interleukin-8 (IL-8) Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR), Enzyme-Linked Immunosorbent Assay (ELISA), other technologies, combine Senescence-Associated β-Galactosidase (SA-β-gal) staining changes aging. IGF-1, PI3K/AKT/mTOR, P16, secretory (SASP) IL-1β, IL-6, IL-8 was increased senescent cells. After treatment jujuboside, protein decreased. findings suggested slowed down inhibiting through IGF-1. These suggest potential new drug its mechanisms anti-aging.

Language: Английский

Citations

0